Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients
Clinical trial NCT04418154 · UNKNOWN
Trial details
- NCT number
- NCT04418154
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2022-09-28
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.